These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4655581)

  • 1. [Disturbed fibrin stabilization in chronic liver diseases and dysproteinemia].
    Braun K; Wenzel E; Breddin K
    Med Welt; 1972 Sep; 23(40):1390-2. PubMed ID: 4655581
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormalities of fibrin stabilization in liver and kidney disease: a comparison of two different methods.
    Walls WD; Losowsky MS
    Clin Sci; 1969 Dec; 37(3):837-46. PubMed ID: 5363577
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reliability of simple examination methods for the measurement of fibrin stabilization and factor XIII activity].
    Popat D; Weber G; Wenzel E
    Med Welt; 1972 Sep; 23(40):1387-9. PubMed ID: 4655580
    [No Abstract]   [Full Text] [Related]  

  • 4. [Individual serum proteins as indicators of dysproteinemia in chronic liver disease].
    Malejev A; Krystev Z; Sipkov T; Kolarski V
    Cesk Gastroenterol Vyz; 1979 Oct; 33(7):421-6. PubMed ID: 509589
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolysis activities and factor XIII in the neonatal period. 2. Relationship between factor XIII and fibrinolysis activities].
    Yamada Z
    Nihon Shonika Gakkai Zasshi; 1971 Apr; 75(4):297-303. PubMed ID: 4252803
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of dysproteinemia in certain liver diseases].
    Tsykin DB
    Klin Med (Mosk); 1975 Jan; 53(1):67-71. PubMed ID: 1134023
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Walls WD; Losowsky MS
    Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma fibrin-stabilizing factor activity in acquired disease.
    Walls WD; Losowsky MS
    Br J Haematol; 1968 Sep; 15(3):327. PubMed ID: 5681498
    [No Abstract]   [Full Text] [Related]  

  • 11. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the blood protein picture (dysproteinemia) in liver diseases in reptiles (Boidae, Pythonidae, Varanidae)].
    Will R
    Zentralbl Veterinarmed B; 1975 Oct; 22(8):635-55. PubMed ID: 1199535
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrin-stabilizing factor in alcoholic liver disease (author's transl)].
    Iwabuchi S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Dec; 78(12):2422. PubMed ID: 7341801
    [No Abstract]   [Full Text] [Related]  

  • 14. [Erythrokinetics in several anemias, polyglobulias, neoplastic and inflammatory diseases, liver diseases and uremias].
    Krebs M; Gelinsky P; Ritter B
    Arztl Forsch; 1969 Sep; 23(9):312-8. PubMed ID: 5307588
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new test for dysproteinemia: the chlorogenic acid tests. II. Application to serums of patients having liver dysfunction].
    Tayeau F; Traissac FJ; Marquevielle J; Séchet J; Duhamel-Reiss A; Gratadour J
    Ann Biol Clin (Paris); 1968; 26(10):1193-201. PubMed ID: 5303987
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of active and potentially active form of factor XIII].
    Yamada K; Yamada Z; Nakazawa S
    Nihon Ketsueki Gakkai Zasshi; 1970 Oct; 33(5):687-9. PubMed ID: 5535823
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolysis and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 52(1):40-6. PubMed ID: 4212014
    [No Abstract]   [Full Text] [Related]  

  • 18. A solid-phase radioassay for factor-XIII activity (fibrin stabilizing factor) in human plasma.
    Schmer G
    Br J Haematol; 1973 Jun; 24(6):735-42. PubMed ID: 4716057
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The serum protein pattern in ethylic hepatopathy].
    Fedeli S; Ranieri MG
    Minerva Med; 1969 Oct; 60(86):4282-90. PubMed ID: 5354509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.